RASP Wealth Solutions’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$151M Sell
130,286
-39,457
-23% -$46.6M 59.24% 1
2026
Q2
$204M Buy
+169,743
New +$173M 67.76% 1

Other funds holding LLY

RASP Wealth Solutions's LLY Position: Q3 2026 in Review

RASP Wealth Solutions reduced its Eli Lilly (LLY) stake by 23% in Q3 2026, selling an estimated $46.6M and leaving 130,286 shares worth $151M. The position accounts for 59.24% of the portfolio, ranked #1.

RASP Wealth Solutions first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. The position peaked at $204M in Q2 2026. 4,599 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • RASP Wealth Solutions held 130,286 shares of Eli Lilly worth $151M as of Q3 2026.
  • RASP Wealth Solutions sold 39,457 Eli Lilly shares in Q3 2026, an estimated $46.6M.
  • Eli Lilly made up 59.24% of RASP Wealth Solutions's portfolio in Q3 2026, its #1 holding.
  • RASP Wealth Solutions first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • RASP Wealth Solutions's Eli Lilly position peaked at $204M in Q2 2026.
  • 4,599 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on RASP Wealth Solutions's 13F filing for Q3 2026, filed 6 Nov 2026.